|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Propylene dichloride |
CAS 78-87-5 | ||
CH3CHClCH2Cl |
RTECS TX9625000 | ||
|
Synonyms & Trade Names Dichloro-1,2-propane; 1,2-Dichloropropane |
DOT ID & Guide 1279 130 |
||
Exposure
|
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL†: TWA 75 ppm (350 mg/m3) | |||
| IDLH Ca [400 ppm] See: 78875 | Conversion 1 ppm = 4.62 mg/m3 | ||
|
Physical Description Colorless liquid with a chloroform-like odor. [pesticide] |
|||
|
MW: 113.0 |
BP: 206°F |
FRZ: -149°F |
Sol: 0.3% |
|
VP: 40 mmHg |
IP: 10.87 eV |
|
Sp.Gr: 1.16 |
|
Fl.P: 60°F |
UEL: 14.5% |
LEL: 3.4% |
|
| Class IB Flammable Liquid: Fl.P. below 73°F and BP at or above 100°F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, strong acids, active metals |
|||
|
Measurement Methods NIOSH 1013; OSHA 7 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, respiratory system; drowsiness, dizziness; liver, kidney damage; in animals: central nervous system depression; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, respiratory system, liver, kidneys, central nervous system Cancer Site [in animals: liver & mammary gland tumors] |
|
| See also: INTRODUCTION See ICSC CARD: 0441 |